GLP-1 is released primarily from the ileum and colon in the response to food intake
Treatment typically involves behavioral therapy, medication or a combination of both to improve focus, emotional regulation and impulse control but some patients taking GLP-1s say theyre experiencing improvements they never achieved with traditional ADHD drugs
If the patient is responding well, a three month prescription cycle is typically provided
March 2, 2026: Gastrointestinal Lawsuits Involving Trulicity, Other GLP-1s Increase in March Eli Lilly and one other drug company are facing 3,363 lawsuits in a consolidated MDL, in which plaintiffs accuse the companies of failing to warn patients about the gastrointestinal risks of taking Trulicity and other GLP-1s
#1: Effective weight loss Sleep apnea and body weight have a two-way relationship, and losing weight can improve many cases of sleep apnea when obesity is a factor